Philips reported weak Q2 results, which missed consensus estimates. Add on top the 2022 guidance downgrade, and the markets have been spooked again. Although, the firm managed to clock marginal (c.1%) order intake growth and implement price hikes, which implies that the Dutch firm is trying hard to stage a performance turnaround. While the respective offerings still hold immense potential, investors for now have no choice but to be patient until the market/macro headwinds abate. Our estimates ar ....
25 Jul 2022
Supply chain and Chinese lockdowns weigh on business recovery; 2022 guidance slashed
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Supply chain and Chinese lockdowns weigh on business recovery; 2022 guidance slashed
Philips reported weak Q2 results, which missed consensus estimates. Add on top the 2022 guidance downgrade, and the markets have been spooked again. Although, the firm managed to clock marginal (c.1%) order intake growth and implement price hikes, which implies that the Dutch firm is trying hard to stage a performance turnaround. While the respective offerings still hold immense potential, investors for now have no choice but to be patient until the market/macro headwinds abate. Our estimates ar ....